AACR Annual Meeting 2017: Immunotherapy Provides Long-lasting Responses to Certain Cancer Types

Now that a plethora of clinical trials have established positive responses from immunotherapies—immune checkpoint inhibitors, in particular—in patients with a variety of cancer types, one of the logical next questions is, are the responses durable?

Read More

Immunotherapy Conference: “Translating Science Into Survival”

Some of the world’s top researchers in the promising field of cancer immunotherapy are gathering in New York this week at the Second International Cancer Immunotherapy Conference, hosted by the Cancer Research Institute (CRI), the Association for Cancer Immunotherapy (CIMT), the European Academy of Tumor Immunology (EATI), and the American Association for Cancer Research (AACR).

Read More